GENE ONLINE|News &
Opinion
Blog

2025-12-02|

Study Explores EEG and ECG Signal Connectivity During Tilt Table Testing in Healthy Young Adults

by GOAI
Share To

A recent study published in *BMC Neuroscience* examines changes in neural and cardiac signal connectivity during tilt table testing among healthy young adults. Researchers Runnova, Zhuravlev, Novikov, and their team conducted the investigation to explore functional interactions between electroencephalogram (EEG) and electrocardiogram (ECG) signals under controlled conditions. The study focused specifically on participants without a history of syncope episodes, aiming to better understand physiological responses during postural changes.

The research highlights how tilt table testing impacts EEG and ECG connectivity, providing detailed observations on the interplay between brain activity and heart function. The findings contribute to understanding how neural and cardiac systems adapt during shifts in posture. This study marks a step forward in analyzing these interactions in individuals with no underlying health issues related to fainting or syncope. Further details regarding methodology and results are available through the journal publication.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: December 2, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top